- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Results
118
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
118 companies
Consun Pharmaceutical Group
Market Cap: HK$12.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.03
7D
-1.0%
1Y
74.4%
Essex Bio-Technology
Market Cap: HK$2.4b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.30
7D
-1.4%
1Y
59.9%
JBM (Healthcare)
Market Cap: HK$2.4b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.96
7D
-0.3%
1Y
153.0%
Jacobson Pharma
Market Cap: HK$2.9b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.45
7D
0.7%
1Y
126.6%
Tong Ren Tang Technologies
Market Cap: HK$5.9b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.64
7D
-1.3%
1Y
-10.6%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.2b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.63
7D
-0.9%
1Y
3.7%
China Resources Pharmaceutical Group
Market Cap: HK$31.3b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.98
7D
1.8%
1Y
-10.1%
WuXi Biologics (Cayman)
Market Cap: HK$147.1b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$36.20
7D
-0.2%
1Y
121.8%
China Shineway Pharmaceutical Group
Market Cap: HK$6.3b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.40
7D
-1.9%
1Y
-9.0%
United Laboratories International Holdings
Market Cap: HK$24.8b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$12.57
7D
-1.5%
1Y
17.3%
Grand Pharmaceutical Group
Market Cap: HK$28.9b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.26
7D
0.9%
1Y
79.6%
China Medical System Holdings
Market Cap: HK$32.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.43
7D
2.5%
1Y
70.4%
SSY Group
Market Cap: HK$9.0b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.10
7D
0.6%
1Y
-18.4%
Shanghai Haohai Biological Technology
Market Cap: HK$11.7b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$27.40
7D
2.2%
1Y
-10.0%
Pak Fah Yeow International
Market Cap: HK$757.3m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.43
7D
1.7%
1Y
-3.2%
Sino Biopharmaceutical
Market Cap: HK$126.4b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$7.07
7D
1.6%
1Y
96.4%
Medtide
Market Cap: HK$4.3b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$30.60
7D
0%
1Y
n/a
CSPC Pharmaceutical Group
Market Cap: HK$87.5b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$7.65
7D
-3.0%
1Y
45.2%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$535.4m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.62
7D
0%
1Y
-31.1%
WuXi XDC Cayman
Market Cap: HK$92.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$75.10
7D
6.5%
1Y
232.3%
Lee's Pharmaceutical Holdings
Market Cap: HK$1.1b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$1.91
7D
-1.5%
1Y
52.8%
3SBio
Market Cap: HK$73.7b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$30.80
7D
10.1%
1Y
425.6%
Simcere Pharmaceutical Group
Market Cap: HK$32.1b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$12.36
7D
-1.0%
1Y
77.8%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.20
7D
-0.8%
1Y
-3.2%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.15
7D
-2.3%
1Y
48.3%
Innovent Biologics
Market Cap: HK$149.1b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$87.00
7D
1.7%
1Y
148.2%
Shandong Xinhua Pharmaceutical
Market Cap: HK$9.9b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.95
7D
-4.3%
1Y
18.4%
Ascletis Pharma
Market Cap: HK$9.6b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$9.65
7D
5.8%
1Y
584.4%
Genscript Biotech
Market Cap: HK$35.2b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$16.10
7D
1.0%
1Y
37.6%
HBM Holdings
Market Cap: HK$11.3b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$13.47
7D
8.3%
1Y
1,022.5%
Modern Chinese Medicine Group
Market Cap: HK$532.8m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.74
7D
4.2%
1Y
127.7%
CanSino Biologics
Market Cap: HK$16.0b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$46.26
7D
8.9%
1Y
70.7%
CStone Pharmaceuticals
Market Cap: HK$9.2b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$6.26
7D
-0.9%
1Y
198.1%
Alphamab Oncology
Market Cap: HK$11.2b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.
9966
HK$11.50
7D
-2.9%
1Y
213.4%
Cutia Therapeutics
Market Cap: HK$2.6b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$7.53
7D
-4.6%
1Y
-38.0%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$104.5b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$448.00
7D
2.4%
1Y
153.1%